The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
It was reported that the procedure was to treat a 90% stenosed lesion in the mid right coronary artery (mrca) with heavy calcification and heavy tortuosity.The 3.5x23mm xience skypoint drug eluting stent (des) was attempted to be advanced to the target lesion, however, failed to cross due to the anatomy.Therefore, the des was removed and resistance was also noted with the anatomy.There was no adverse patient effect and no clinically significant delay reported in the procedure.No additional information was provided.
|